Log in to save to my catalogue

BCL-XL directly modulates RAS signalling to favour cancer cell stemness

BCL-XL directly modulates RAS signalling to favour cancer cell stemness

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d8e0c073724f4c88b43e7f5e0debd8b0

BCL-XL directly modulates RAS signalling to favour cancer cell stemness

About this item

Full title

BCL-XL directly modulates RAS signalling to favour cancer cell stemness

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2017-10, Vol.8 (1), p.1-11, Article 1123

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

In tumours, accumulation of chemoresistant cells that express high levels of anti-apoptotic proteins such as BCL-X
L
is thought to result from the counter selection of sensitive, low expresser clones during progression and/or initial treatment. We herein show that BCL-X
L
expression is selectively advantageous to cancer cell populations...

Alternative Titles

Full title

BCL-XL directly modulates RAS signalling to favour cancer cell stemness

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d8e0c073724f4c88b43e7f5e0debd8b0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d8e0c073724f4c88b43e7f5e0debd8b0

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-017-01079-1

How to access this item